3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
5
Stomach Neoplasms
2
Colonic Polyps
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Polyps
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Margins of Excision
1
Lung Neoplasms
1
Laryngeal Diseases
1
Inflammatory Bowel Diseases
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Barrett Esophagus
1
Adenomatous Polyps
1
Adenoma
1
Adenocarcinoma
1
Interventions
Infliximab
3
Tea
2
Polyethylene Glycols
2
Lidocaine
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
sodium phosphate
1
purine
1
prucalopride
1
picosulfate sodium
1
golimumab
1
fumaric acid
1
Sulfasalazine
1
Pneumococcal Vaccines
1
Passive Cutaneous Anaphylaxis
1
Papillomavirus Vaccines
1
Narrow Band Imaging
1
Morphine
1
Methotrexate
1
Mesalamine
1
Mercaptopurine
1
MEDI2070
1
Exercise
1
Etanercept
1
Dietary Supplements
1
Diatrizoate Meglumine
1
Diagnostic Imaging
1
Calcium Dobesilate
1
CT-P13
1
Bupivacaine
1
Bisacodyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Inflammatory Bowel Diseases
×
Narrow Band Imaging
×
Clear all
NCT01688557
2016-10-07
RCT-IC
Jagiellonian University
Phase NA
Completed
600 enrolled